Cosmos Health Projects $3.2M U.S. Annual Revenue from Fort18 Launch
Cosmos Health expects Fort18 to generate over $3.2 million in incremental annual U.S. revenue within 12-18 months, launching commercially in June 2026 via direct-to-consumer e-commerce followed by selected retail expansion. The U.S. sexual health supplement market, valued at $965.8 million in 2023, is projected to reach $1.93 billion by 2030.
1. Fort18 Revenue Projection
Cosmos Health projects Fort18™ will deliver over $3.2 million in incremental annual U.S. revenue within the next 12 to 18 months. This forecast is based on internal assumptions covering pricing, anticipated sales volumes, repeat purchase rates and distribution growth.
2. Commercial Launch Strategy
The company plans a staged rollout beginning with direct-to-consumer e-commerce in June 2026, followed by expansion into selected retail channels. This approach aims to build brand awareness online before leveraging physical retail partnerships.
3. U.S. Market Opportunity
The U.S. sexual health supplement market was valued at $965.8 million in 2023 and is expected to grow at a 10.4% CAGR to $1.93 billion by 2030. Fort18 targets men’s stamina and endurance within this rapidly expanding segment.
4. Company Overview
Cosmos Health is a diversified, vertically integrated global healthcare group with proprietary pharmaceutical and nutraceutical brands, European GMP-certified manufacturing, R&D partnerships and a telehealth arm. Its portfolio includes Sky Premium Life®, Mediterranation®, bio-bebe® and C-Sept® products.